Yahoo Finance

Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ascopubs.org

Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center

We validated a clinical bait-capture WTS assay using 78 solid tumor samples across diverse tissue types, including 59 with known fusions or oncogenic splice variants. Sensitivity was assessed against ...
Business Insider

Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI ...

Caris to develop CDx for Debiopharm's FUZE Phase II Pivotal Trial of Debio 1347 in solid tumor patients with FGFR fusions IRVING, Texas, June 3, 2019 /PRNewswire/ -- Caris Life Sciences ®, a leading ...
Medscape

Tissue Microarrays

Another study by Terry et al. used TMAs as part of an implementation of the Canadian External Quality Assurance program for breast cancer testing. [61] The study included TMAs with 38 independent ...